Fig. 2From: Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical studyNumber of days the device was not used by patient satisfaction over the 3-months active treatment period with Cefaly®Back to article page